Bausch + Lomb (NYSE:BLCO) received US FDA clearance for its Bi-Blade+ dual-port vitrectomy cutter and Adaptive Fluidics update, expanding its retina surgery toolkit. The company launched the enVista ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...

FDA clearance for its Bi-Blade+ advanced dual-port vitrectomy cutter and Adaptive Fluidics update for the Stellaris Elite ...

The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to understand various aspects before the procedure.

Adam Jacobson, MD, and colleagues retrospectively investigated how glaucoma affects the eyes of pediatric patients with ...

The VFFQ-23 may outperform the VFQ-25 in identifying patients likely to benefit from surgical treatment for vitreous floaters.

Hello, Dear Readers! Just a quick update to let you know that my eye surgery (a vitrectomy for vitreomacular traction) took ...

Dry age-related macular degeneration (AMD) management is currently based on regular follow-up for early detection of choroidal neovascularization (CNV), addressing the risk factors and prescribing ...

The safety of retina surgery depends on two factors which are the experience of the surgeon and the use of contemporary surgical techniques. The ongoing development of surgical instruments together ...

The harmless 'floaters' popping up in your field of vision could be a sign of permanent eye damage or oncoming blindness, a ...